GENB Generate Biomedicines leadership flags accelerated AI drug pipeline advancement as top priority in latest quarterly earnings update Is Innovative LUCYW stock worth considering for entry RVMD Revolution Medicines edges higher after reporting wider than expected Q4 2025 per share loss US Government and Frontier AI Firm Collaboration Talks Amid Ongoing Procurement Litigation What yield trap Gorilla GRRRW Marginal Loss 20260427